Clarifies provisions relating to certificates of qualification for clinical laboratories and blood banks.
Summary
S00765 amends the Public Health Law to clarify who may receive a certificate of qualification to operate a clinical laboratory or blood bank. Under the bill, the Department of Health would continue to issue certificates to applicants who meet minimum qualifications set by the department, but the bill adds that those qualifications must be consistent with federal regulations and include board certification where required. The bill also retains the existing requirement that applicants demonstrate character, competence, training, and ability to properly administer the technical and scientific operations of a clinical laboratory or blood bank, including supervision of testing and reporting.
The bill also makes a conforming change to a separate Public Health Law provision governing the department’s authority to prescribe qualifications for various public health personnel. It removes a bracketed reference to “directors or other persons in charge of laboratories” from that list, reflecting the bill’s narrower focus on laboratory and blood bank certification standards rather than general personnel qualification rules. The measure is intended to take effect on the same date and in the same manner as a related 2024 chapter law concerning certificates of qualification for clinical laboratories and blood banks.
Impact
If enacted, the bill would affect Public Health Law sections governing Department of Health certification authority for clinical laboratories and blood banks, as well as the department’s broader personnel-qualification rulemaking language. It would likely influence applicants, laboratory directors, blood bank operators, and the Department of Health by tying qualification standards more explicitly to federal regulations and board certification requirements, while preserving the department’s discretion to assess competence and training.
Sentiment
There is no recorded committee transcript or vote history in the provided materials, so the bill’s sentiment cannot be measured from debate or roll call. Based on the text and caption, the measure appears technical and administrative in nature, aimed at clarifying existing certification standards rather than creating a controversial new policy.
Contention
No specific points of contention are documented in the provided materials. Potential areas of interest, if discussed, would likely involve whether the added reference to federal regulations and board certification could narrow the pool of eligible laboratory or blood bank directors, and whether the Department of Health should retain broad discretion versus adopting more explicit statutory standards. However, no opposing or supporting arguments are included in the record provided.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.
Permits out-of-state clinical laboratories located within the United States to accept specimens from New York when there are no proper labs within the state recognized by the department of health.